ZANOTTI, Laura
 Distribuzione geografica
Continente #
NA - Nord America 2.176
EU - Europa 932
AS - Asia 433
AF - Africa 3
SA - Sud America 3
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 1
Totale 3.550
Nazione #
US - Stati Uniti d'America 2.161
PL - Polonia 354
CN - Cina 254
UA - Ucraina 172
DE - Germania 126
IT - Italia 97
HK - Hong Kong 87
FI - Finlandia 64
SG - Singapore 44
GB - Regno Unito 36
IE - Irlanda 35
FR - Francia 20
VN - Vietnam 20
CA - Canada 13
SE - Svezia 9
IN - India 7
BE - Belgio 5
KR - Corea 5
TW - Taiwan 4
BG - Bulgaria 3
BR - Brasile 3
CZ - Repubblica Ceca 3
KG - Kirghizistan 3
EU - Europa 2
IQ - Iraq 2
JP - Giappone 2
LK - Sri Lanka 2
MX - Messico 2
NL - Olanda 2
RU - Federazione Russa 2
AU - Australia 1
CH - Svizzera 1
EE - Estonia 1
EG - Egitto 1
KZ - Kazakistan 1
LU - Lussemburgo 1
MA - Marocco 1
MU - Mauritius 1
PT - Portogallo 1
TR - Turchia 1
UZ - Uzbekistan 1
Totale 3.550
Città #
Warsaw 354
Fairfield 333
Woodbridge 234
Houston 170
Seattle 169
Ashburn 155
Chandler 144
Jacksonville 132
Cambridge 117
Wilmington 105
Ann Arbor 93
Dearborn 92
New York 76
Hong Kong 70
Princeton 64
Helsinki 47
Nanjing 40
Dublin 35
Brescia 34
Beijing 33
Shanghai 30
Singapore 23
Dong Ket 20
Jinan 18
Shenyang 16
Des Moines 14
Central 13
Changsha 12
Nanchang 12
Toronto 12
Hebei 11
Kunming 10
Jiaxing 9
Hangzhou 8
London 8
Milan 8
San Diego 8
Tianjin 8
Los Angeles 7
Lanzhou 6
Monmouth Junction 6
Brussels 5
Hefei 5
Norwalk 5
San Francisco 5
Zhengzhou 5
Cazzago San Martino 4
Leawood 4
Nardò 4
Ningbo 4
Bishkek 3
Brno 3
Fuzhou 3
Guangzhou 3
Gunzenhausen 3
Haikou 3
Lancaster 3
North 3
Rome 3
Sofia 3
Taoyuan District 3
Augusta 2
Baghdad 2
Baton Rouge 2
Boardman 2
Cheongju-si 2
Colombo 2
Islington 2
Kilburn 2
Mexico City 2
New Bedfont 2
Paris 2
Phoenix 2
Salerno 2
San Bruno 2
San Mateo 2
South San Francisco 2
São Paulo 2
Taizhou 2
Tokyo 2
Verona 2
Wuhan 2
Xian 2
Almaty 1
Almere Stad 1
Aveiro 1
Borgo San Giacomo 1
Buccinasco 1
Cairo 1
Casalpusterlengo 1
Catania 1
Chengdu 1
Chicago 1
Falkenstein 1
Fulham 1
Göttingen 1
Hanover 1
Hounslow 1
Istanbul 1
Lappeenranta 1
Totale 2.891
Nome #
Identification of stably expressed reference small non-coding RNAs for microRNA quantification in high-grade serous ovarian carcinoma tissues 283
Proc Natl Acad Sci U S A. 2013 Feb 19;110(8):2916-21. doi: 10.1073/pnas.1222577110. Epub 2013 Jan 28. Landscape of somatic single-nucleotide and copy-number mutations in uterine serous carcinoma. Zhao S1, Choi M, Overton JD, Bellone S, Roque DM, Cocco E, Guzzo F, English DP, Varughese J, Gasparrini S, Bortolomai I, Buza N, Hui P, Abu-Khalaf M, Ravaggi A, Bignotti E, Bandiera E, Romani C, Todeschini P, Tassi R, Zanotti L, Carrara L, Pecorelli S, Silasi DA, Ratner E, Azodi M, Schwartz PE, Rutherford TJ, Stiegler AL, Mane S, Boggon TJ, Schlessinger J, Lifton RP, Santin AD 242
Evaluation of a novel human IgG1 anti-claudin3 antibody that specifically recognizes its aberrantly localized antigen in ovarian cancer cells and that is suitable for selective drug delivery 219
Circulating miRNA landscape identifies miR-1246 as promising diagnostic biomarker in high-grade serous ovarian carcinoma: A validation across two independent cohorts 147
Mutational landscape of uterine and ovarian carcinosarcomas implicates histone genes in epithelial-mesenchymal transition 141
Landscape of somatic single-nucleotide and copy-number mutations in uterine serous carcinoma 136
Secretoglobin expression in ovarian carcinoma: lipophilin B gene upregulation as an independent marker of better prognosis. 136
Identification of optimal reference genes for gene expression normalization in a wide cohort of endometrioid endometrial carcinoma tissues. 127
Epidermal growth factor receptor detection in serum and saliva as a diagnostic and prognostic tool in oral cancer 127
RERT: A Novel Regression Tree Approach to Predict Extrauterine Disease in Endometrial Carcinoma Patients 126
Trop-2 overexpression as an independent marker for poor overall survival in ovarian carcinoma patients. 125
Altered immunolocalization of heat-shock proteins in human peri-implant gingiva 119
Mammaglobin B is an independent prognostic marker in epithelial ovarian cancer and its expression is associated with reduced risk of disease recurrence 119
Trop-2 protein overexpression is an independent marker for predicting disease recurrence in endometrioid endometrial carcinoma 114
MAL gene overexpression as a marker of high-grade serous ovarian carcinoma stem-like cells that predicts chemoresistance and poor prognosis 111
Role of the novel generation of androgen receptor pathway targeted agents in the management of castration-resistant prostate cancer: A literature based meta-analysis of randomized trials 109
The HIV-protease inhibitor saquinavir reduces proliferation, invasion and clonogenicity in cervical cancer cell lines 107
A Phase Ib Open-Label Study to Assess the Safety and Tolerability of Everolimus in Combination with Eribulin in Triple-Negative Breast Cancers 106
Incidence and relative risk of adverse events of special interest in patients with castration resistant prostate cancer treated with CYP-17 inhibitors: A meta-analysis of published trials 105
Functional characterization of epithelial ovarian cancer histotypes by drug target based protein signaling activation mapping: Implications for personalized cancer therapy 104
Human epididymis protein 4 as a serum marker for diagnosis of endometrial carcinoma and prediction of clinical outcome 84
Room-temperature gas sensing based on visible photoluminescence properties of metal oxide nanobelts 80
Oxide nanobelts as conductometric gas sensors 79
Low Expression of Claudin-7 as Potential Predictor of Distant Metastases in High-Grade Serous Ovarian Carcinoma Patients 75
Claudin 7 downregulation is predictive of distant metastasis in high-grade serous carcinoma patients 73
Genome-wide study of salivary miRNAs identifies miR-423-5p as promising diagnostic and prognostic biomarker in oral squamous cell carcinoma 69
Gas sensitive light emission properties of tin oxide nanobelts 58
Expression profiles of PRKG1, SDF2L1 and PPP1R12A are predictive and prognostic factors for therapy response and survival in high-grade serous ovarian cancer 53
FXYD5 (Dysadherin) upregulation predicts shorter survival and reveals platinum resistance in high-grade serous ovarian cancer patients 53
The claudin-low subtype of high-grade serous ovarian carcinoma exhibits stem cell features 53
Pre-treatment Serum HE4 Level as a Novel Independent Prognostic Biomarker for Uterine Cervical Carcinoma Patients 47
L1CAM expression as a predictor of platinum response in high-risk endometrial carcinoma 44
Infiltration by CXCL10 Secreting Macrophages Is Associated With Antitumor Immunity and Response to Therapy in Ovarian Cancer Subtypes 22
VEGF-D Serum Level as a Potential Predictor of Lymph Node Metastasis and Prognosis in Vulvar Squamous Cell Carcinoma Patients 21
Integrated Biomarker Analysis Reveals L1CAM as a Potential Stratification Marker for No Specific Molecular Profile High-Risk Endometrial Carcinoma 20
Totale 3.634
Categoria #
all - tutte 15.077
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 15.077


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020969 102 45 34 95 66 146 131 103 76 102 23 46
2020/2021636 13 57 10 75 24 55 35 80 62 121 64 40
2021/2022343 43 59 5 4 1 15 24 16 11 49 43 73
2022/2023377 58 24 20 25 31 70 3 39 63 4 21 19
2023/2024476 27 14 47 36 24 113 23 37 79 26 9 41
2024/20251 1 0 0 0 0 0 0 0 0 0 0 0
Totale 3.634